In that study, adding CAF or other A2A blockers allowed cytotoxic T lymphocytes to overcome the suppressive tumor microenvironment, leading to greater tumor inhibition and even eradication of metastases. This evidence concerns the gene IGKV2D-29 and neoplasm.